Skip to evidence report

NEU.INH_VIP.develop_niche: Studies — page 11

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 122 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 10,001–11,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for NEU.INH_VIP.develop_niche
#Trait / studyIndividual trait IDMean IC score
10001Other haemoglobinopathiesFING000010533.81e-04
10002TGFBR3 levelsGCST904708483.79e-04
10003CNTNAP4 levelsGCST904688093.79e-04
10004Oral glucose tolerance test-0hGCST902977883.79e-04
10005GNLY levelsGCST904693723.79e-04
10006Nephrotic syndromeGCST900186643.78e-04
10007CD14 levelsGCST904685983.78e-04
10008Lysophosphatidylcholine (24:0) [sn1] levelsGCST900254253.78e-04
10009NUB1/SRPK2 ratioGCST903155733.77e-04
10010Saturated fatty acids to total fatty acids percentageGCST905026973.77e-04
10011CCL2 levelsGCST904685813.77e-04
10012ERN1 levelsGCST904691483.77e-04
10013AMBP/RARRES2 ratioGCST903132563.76e-04
10014IDP dMRI ProbtrackX ISOVF str rGCST900045493.76e-04
10015Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T24ECGU0000243.76e-04
10016SPINK4 levelsGCST904707233.76e-04
10017ADIPOQ levelsGCST902930863.75e-04
10018ADGRE5 levelsGCST904254843.74e-04
10019Bladder stoneGCST904681163.74e-04
10020ART3 levelsGCST904683703.74e-04
10021NCK2 levelsGCST904700073.74e-04
10022Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T465ECGU0004653.74e-04
10023ABHD14B/CCS ratioGCST903131393.74e-04
10024SUGT1 levelsGCST904707803.74e-04
10025PPP1R12A/SPARC ratioGCST903157123.73e-04
10026SH2D1A levelsGCST904706173.73e-04
10027C4BPB/ENTPD5 ratioGCST903135563.72e-04
10028Phospholipids in very small VLDL (UKB data field 23518)GCST902696153.72e-04
10029CIAPIN1 levelsGCST904687533.71e-04
10030CCN2/MGLL ratioGCST903137143.68e-04
10031Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T105ECGU0001053.66e-04
10032EFNA4/TNFRSF10B ratioGCST903146053.65e-04
10033Coronary atherosclerosis (PheCode 411.4)GCST900439573.65e-04
10034FUOM levelsGCST904692763.65e-04
10035CLPS/CTRB1 ratioGCST903141393.65e-04
10036Free androgen indexGCST902398243.65e-04
10037TBCB levelsGCST904708133.65e-04
10038EGF/PPIB ratioGCST903146123.64e-04
10039Deoxycholic acid glucuronide metabolite levelGCST906162293.63e-04
10040REST UKBBICA NODEamps25 0016GCST903854993.63e-04
10041CXCL6/DFFA ratioGCST903143573.62e-04
10042EEF1D levelsGCST904690753.61e-04
10043Triglycerides to Total Lipids in Small VLDL percentageGCST904999223.61e-04
10044FOXO1/NUB1 ratioGCST903148743.60e-04
10045Phospholipids to Total Lipids in Small HDL percentageGCST904994943.59e-04
10046Benign lipomatous neoplasmFING000001463.59e-04
10047LRCH4 levelsGCST904697913.59e-04
10048CBLN4 levelsGCST904685543.59e-04
10049aparc-a2009s rh volume G+S-subcentralGCST900030023.58e-04
10050GGH levelsGCST904693353.58e-04
10051DNAJA2/PRDX5 ratioGCST903145063.58e-04
10052End-diastolic bi-ventricular shape (principal component 1)GCST904484803.58e-04
10053FCRL1/TNFRSF13C ratioGCST903147963.56e-04
10054Total Phosphatidylethanolamine levelsGCST900252073.56e-04
10055Lymphoid leukemia, chronic (PheCode 204.12)GCST904756133.55e-04
10056Phosphatidylethanolamine_40:6_[M-H]1- levelsGCST900603653.54e-04
10057DSG3/FABP9 ratioGCST903145593.54e-04
10058STROKEFING000013363.54e-04
10059Cholesteryl ester levels in small HDLGCST900929463.54e-04
10060TNFRSF14/TNFRSF1A ratioGCST903159353.54e-04
10061DSG4/FABP9 ratioGCST903145623.53e-04
10062Linoleic acid to total fatty acids percentageGCST905020233.53e-04
10063Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levelsGCST900602773.52e-04
10064Gestational thrombocytopeniaGCST903022343.50e-04
10065NAAA levelsGCST904699913.50e-04
10066Concentration of HDL particlesGCST904974063.50e-04
10067CD3 on Terminally Differentiated CD4+ T cellGCST900018443.49e-04
10068CCL14/CST3 ratioGCST903136793.49e-04
10069NUB1 levelsGCST904700993.49e-04
10070TNFSF14 levelsGCST904709223.49e-04
10071Phospholipids in very large HDLGCST905004513.48e-04
10072Glomerular filtration rate (creatinine)GCST0033723.47e-04
10073Cholesteryl esters to total lipids in small HDL percentage (UKB data field 23646)GCST902697433.47e-04
10074Acute osteomyelitis (PheCode 710.11)GCST904762223.47e-04
10075SGSH levelsGCST904706153.47e-04
10076HHEX levelsGCST904694513.46e-04
10077SMPDL3A levelsGCST904706863.46e-04
10078SnoringGCST0097613.45e-04
10079DTI autoptx MD cgc l tractGCST903852243.45e-04
10080ITGB1BP2/PTPN6 ratioGCST903152183.42e-04
10081GP6/LGALS8 ratioGCST903149643.41e-04
10082DAG1/PDGFB ratioGCST903143793.40e-04
10083IL6 levelsGCST904696043.40e-04
10084LILRA5 levelsGCST904697743.40e-04
10085Hypoplasia of dental enamel, including avohilmoFING000006523.40e-04
10086T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102)GCST903206653.39e-04
10087EPHA2 levelsGCST904691303.39e-04
10088TMSB10/TRIAP1 ratioGCST903159243.39e-04
10089Cholesteryl Esters in IDLGCST904975233.39e-04
10090DTI autoptx MD ilf l tractGCST903852343.38e-04
10091DECR1 levelsGCST904689783.38e-04
10092GALNT2 levelsGCST904692963.38e-04
10093SOST/SPP1 ratioGCST903158713.37e-04
10094Phospholipids to Total Lipids in Very Small VLDL percentageGCST905008663.36e-04
10095Heel quantitative ultrasound index (QUI), direct entry | Bone-densitometry of heelUKBB000003243.36e-04
10096CCL15 levelsGCST904685673.36e-04
10097Heel bone mineral density (BMD) T-score, automated | Bone-densitometry of heelUKBB000003183.36e-04
10098AsthmaGCST900185753.35e-04
10099DTI TBSS L2 Posterior thalamic radiation RGCST903845043.35e-04
10100Monounsaturated fatty acids to total fatty acids percentageGCST905023733.35e-04
10101Heel bone mineral density (BMD) | Bone-densitometry of heelUKBB000003153.35e-04
10102LBR/POLR2F ratioGCST903152973.35e-04
10103GSTA3 levelsGCST904694123.35e-04
10104CHL1 levelsGCST904687453.34e-04
10105F11R/PLXNA4 ratioGCST903147243.34e-04
10106SLITRK2 levelsGCST904706703.33e-04
10107IDP dMRI TBSS OD Posterior corona radiata RGCST900044283.33e-04
10108Heel Broadband ultrasound attenuation, direct entry | Bone-densitometry of heelUKBB000003213.33e-04
10109aparc-DKTatlas lh area superiorparietalGCST900032613.33e-04
10110DNAJB1/STIP1 ratioGCST903145133.33e-04
10111Treatment or medication use - atorvastatin (UKB data field 20003_1141146234)GCST900423763.32e-04
10112PODXL2/SEZ6L ratioGCST903157023.31e-04
10113KLK8/LY6D ratioGCST903152573.31e-04
10114HBEGF/YES1 ratioGCST903150393.31e-04
10115SCN4B levelsGCST904705513.30e-04
10116Suppurative and unspecified otitis mediaFING000013463.29e-04
10117IDP dMRI TBSS ICVF Cerebral peduncle LGCST900043423.29e-04
10118MBL2 levelsGCST904698683.27e-04
10119ARHGEF1 levelsGCST904683593.27e-04
10120FGF21 levelsGCST902747883.27e-04
10121OMG levelsGCST904701243.26e-04
10122HippSubfield lh volume CA4-bodyGCST900026833.26e-04
10123Allergic rhinitisGCST900860423.26e-04
10124Alanine transaminase (ALT, maximum, inv-norm transformed)GCST904751093.25e-04
10125DLL1/NBL1 ratioGCST903144963.24e-04
10126Transient global amnesiaFING000013743.24e-04
10127Forearm length to body height ratioGCST902702573.24e-04
10128BSG/CKAP4 ratioGCST903135313.23e-04
10129ASGR2 levelsGCST904683763.23e-04
10130Type 2 diabetesGCST0054133.22e-04
10131Platelet countGCST900187493.22e-04
10132Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T226ECGU0002263.20e-04
10133Saturated fatty acids to total fatty acids percentage (UKB data field 23455)GCST902695523.19e-04
10134PLEKHO1 levelsGCST904702563.18e-04
10135FAS levelsGCST904691923.17e-04
10136Cholesterol in medium HDL (UKB data field 23568)GCST902696653.16e-04
10137SMOC2 levelsGCST904706833.16e-04
10138A body shape indexGCST900200243.15e-04
10139BRAP levelsGCST904684643.14e-04
10140FHIT/PMVK ratioGCST903148223.12e-04
10141Cholesteryl Esters to Total Lipids in Small HDL percentageGCST904994033.11e-04
10142Cholesteryl esters in small HDL (UKB data field 23576)GCST902696733.10e-04
10143Mean corpuscular hemoglobin concentrationGCST0046053.10e-04
10144PDGFA/PLA2G4A ratioGCST903156153.09e-04
10145CXCL11/SDC4 ratioGCST903143363.08e-04
10146rfMRI amplitudes (ICA25 node 14)GCST900045813.08e-04
10147Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB000005133.07e-04
10148Sphingomyelin_38:2_[M+H]1+ levelsGCST900603023.07e-04
10149PDGFRA levelsGCST904701913.06e-04
10150ADAMTS13 levelsGCST904682223.06e-04
10151XG levelsGCST904710823.05e-04
10152Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T92ECGU0000923.05e-04
10153FXN levelsGCST904692823.04e-04
10154FGF23 levelsGCST904692233.03e-04
10155MATN2/SCARA5 ratioGCST903153883.03e-04
10156Total concentration of lipoprotein particlesGCST905001033.02e-04
10157VSTM1 levelsGCST904710553.02e-04
10158Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T114ECGA0001143.01e-04
10159DAAM1 levelsGCST904689413.01e-04
10160IGFBP4 levelsGCST904695303.00e-04
10161Triglycerides to total lipids ratio in chylomicrons and extremely large VLDLGCST900930513.00e-04
10162Mean bone marrow fat fraction of left and right proximal femurGCST906523942.99e-04
10163Cholesterol to Total Lipids in Small HDL percentageGCST904993692.99e-04
10164ICA1/TANK ratioGCST903151122.98e-04
10165Neutrophil percentage of white cells varianceGCST905657012.98e-04
10166Falls/tendency to fallFING000005302.98e-04
10167DSG3 levelsGCST904690432.97e-04
10168Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST904993402.96e-04
10169CALCA levelsGCST904685282.96e-04
10170SARG levelsGCST904705262.96e-04
10171NCR1 levelsGCST904700092.96e-04
10172MESD levelsGCST904698912.96e-04
10173Diastolic blood pressure x sex interactionGCST903351752.96e-04
10174BOC levelsGCST904684582.93e-04
10175Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T487ECGU0004872.93e-04
10176Monounsaturated fatty acid levelsGCST905020302.92e-04
10177PRKAR2A levelsGCST904703272.92e-04
10178GPC1/ITGB6 ratioGCST903149772.92e-04
10179Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levelsGCST902000982.91e-04
10180FABP5/PPCDC ratioGCST903147632.91e-04
10181PTPRF/SDC1 ratioGCST903157522.91e-04
10182Volume of right cortical nucleusGCST904750332.91e-04
10183Immature reticulocyte fraction | Blood countUKBB000003552.90e-04
10184Metabolic disorder, other/unspecifiedFING000008152.89e-04
10185Abdominal aortic aneurysm (PheCode 442.11)GCST904759942.89e-04
10186Linoleic acid to total fatty acids percentageGCST905023332.88e-04
10187TNFRSF12A levelsGCST904709042.88e-04
10188Linoleic acid to total fatty acids percentageGCST904983212.87e-04
10189CXCL10/WARS ratioGCST903143322.87e-04
10190CPE levelsGCST904688412.87e-04
10191CC2D1A/TMSB10 ratioGCST903136672.87e-04
10192Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023972.86e-04
10193CTSC levelsGCST904689092.85e-04
10194CDH5/NOTCH1 ratioGCST903139572.85e-04
10195DTD1 levelsGCST904690452.84e-04
10196Concentration of large VLDL particlesGCST904982232.83e-04
10197HTRA2/TRIAP1 ratioGCST903150992.82e-04
10198DAPP1/SDC4 ratioGCST903143992.82e-04
10199CDH5/TEK ratioGCST903139612.82e-04
10200ADAM12 levelsGCST904682162.82e-04
10201Saturated fatty acids levelsGCST905026742.81e-04
10202GKN1 levelsGCST904693532.81e-04
10203PCDH7 levelsGCST904701712.80e-04
10204PDGFB/PPP1R12A ratioGCST903156232.80e-04
10205MSTN/RGMA ratioGCST903155042.80e-04
10206Ptosis of eyelidFING000012272.79e-04
10207ASRGL1 levelsGCST904683792.78e-04
10208Eosinophil percentage of white cells varianceGCST905656902.78e-04
10209Rosacea (PheCode 695.3)GCST904761782.78e-04
10210PLA2G4A/SDC4 ratioGCST903156682.77e-04
10211IDP dMRI TBSS OD Genu of corpus callosumGCST900044042.77e-04
10212SERPINF1 levelsGCST904705982.77e-04
10213IDP T1 FAST ROIs L subcallosal cortexGCST900025032.77e-04
10214SIGLEC7 levelsGCST904706352.77e-04
10215CRNN levelsGCST904688692.77e-04
10216Pulmonary embolismFING000012282.77e-04
10217Creatinine levels (UKB data field 23478)GCST902695752.76e-04
10218CD226 levelsGCST904686092.76e-04
10219Triglycerides to Total Lipids in IDL percentageGCST904976762.75e-04
10220Status post-amiFING000013332.75e-04
10221Lung cancerGCST0047482.75e-04
10222Phospholipids in very small VLDLGCST905008512.75e-04
10223Hypertensive chronic kidney disease (PheCode 401.22)GCST904759272.74e-04
10224VNN1 levelsGCST904710432.74e-04
10225Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626)GCST902697232.74e-04
10226Operation code - inguinal hernia repair | OperationsUKBB000005602.73e-04
10227T1 FreeSurfer DKT lh lateraloccipital areaGCST903842022.73e-04
10228LPL levelsGCST904697882.73e-04
10229MIA/NBL1 ratioGCST903154452.72e-04
10230Inflammatory bowel disease, strict (require KELA)FING000006752.71e-04
10231CEP43/USP8 ratioGCST903140222.71e-04
10232UMOD levelsGCST904710092.71e-04
10233CDKN1A/DAB2 ratioGCST903139672.69e-04
10234Conduction disordersFING000003242.69e-04
10235SNAP29/SNX9 ratioGCST903158592.69e-04
10236BTN2A1/IFNGR1 ratioGCST903135432.69e-04
10237Degree of unsaturationGCST905027462.69e-04
10238FUT8/TNFSF12 ratioGCST903148942.68e-04
10239HAVCR1 levelsGCST900120412.68e-04
10240Red blood cell countGCST0046012.68e-04
10241TRAF3 levelsGCST904709572.67e-04
10242DTI autoptx L3 unc l tractGCST903852182.66e-04
10243Benign neoplasm of colon, rectum, anus and anal canal | Benign neoplasmsUKBB000000932.65e-04
10244Serum phosphate levelsGCST900259482.65e-04
10245Total Lipids in HDLGCST904973932.65e-04
10246CST3/TIMP1 ratioGCST903143002.64e-04
10247S100A4 levelsGCST904705182.64e-04
10248PLA2G2A levelsGCST904702472.64e-04
10249Lymphocyte countGCST900187422.63e-04
10250CD58/IFNGR1 ratioGCST903138492.63e-04
10251BCAM/EPO ratioGCST903134712.61e-04
10252PIBF1 levelsGCST904702312.60e-04
10253PollinosisGCST900186832.60e-04
10254FGFR2/TGFBR2 ratioGCST903148132.59e-04
10255PTPN6/SNAP23 ratioGCST903157472.59e-04
10256PILRA levelsGCST904702362.59e-04
10257COMMD1 levelsGCST904688252.59e-04
10258Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T59ECGA0000592.58e-04
10259LPP levelsGCST904697902.58e-04
10260CD300E/CD59 ratioGCST903137942.57e-04
10261SERPINB1/SERPINB6 ratioGCST903158262.56e-04
10262Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T26ECGU0000262.56e-04
10263MAVS/RNF41 ratioGCST903153952.56e-04
10264CCL3 levelsGCST904685822.56e-04
10265DSG3/SPINK5 ratioGCST903145612.55e-04
10266BAP18 levelsGCST904684222.55e-04
10267Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T56ECGA0000562.54e-04
10268VCAM1 levelsGCST902433172.53e-04
10269ST3GAL1 levelsGCST904707522.53e-04
10270SRC levelsGCST904707412.52e-04
10271CTRB1/PLA2G1B ratioGCST903143072.52e-04
10272SKAP2/VSIR ratioGCST903158492.51e-04
10273AHSP/HMBS ratioGCST903132172.50e-04
10274CD8 on Effector Memory CD8+ T cellGCST900020562.50e-04
10275CD79B levelsGCST904686482.49e-04
10276IDP dMRI TBSS MO FornixGCST900039572.49e-04
10277Triglyceride levels in HDLGCST900928292.48e-04
10278Hard cardiovascular diseasesFING000006022.47e-04
10279Phospholipids in small HDLGCST904994782.47e-04
10280Other venous embolism and thrombosis (PheCode 452)GCST904760072.47e-04
10281Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74)GCST906685182.47e-04
10282Carotid intima-media thickness (MTAG)GCST904490612.46e-04
10283Otitis externa, unspecifiedFING000011292.46e-04
10284TACC3/TBC1D23 ratioGCST903159002.46e-04
10285Platelet count (UKB data field 30080)GCST904680952.46e-04
10286Urea | Blood biochemistryUKBB000008852.45e-04
10287DTI autoptx FA ifo r tractGCST903851252.45e-04
10288Osteoporosis | musculoskeletalUKBB000005982.45e-04
10289APOL1 levelsGCST904683412.45e-04
10290X-12411 levelsGCST902004922.44e-04
10291Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T95ECGU0000952.44e-04
10292MZB1/TNFRSF13B ratioGCST903155092.43e-04
10293Heel bone mineral densityGCST0062882.43e-04
10294GP2/LGALS8 ratioGCST903149612.42e-04
10295Triglycerides in large VLDLGCST904982672.42e-04
10296BCL2L1 levelsGCST904684322.42e-04
10297Posterior diffusion tensor imaging along the perivascular space indexGCST904555452.42e-04
10298Bifidobacterium kashiwanohense abundance in stoolGCST900322262.41e-04
10299NRSN1 levelsGCST902420622.40e-04
10300ITGA5/LILRA2 ratioGCST903152042.40e-04
10301Lymphocyte countGCST900023882.39e-04
10302DTI autoptx L3 ilf l tractGCST903852072.39e-04
10303CNTN4 levelsGCST904688062.39e-04
10304Takes medication for peripheral vascular disease?GCST904752202.39e-04
10305Cholesterol to Total Lipids in Medium HDL percentageGCST904985162.39e-04
10306CR2/TNFRSF13B ratioGCST903142252.38e-04
10307CX3CL1/EPHB6 ratioGCST903143242.38e-04
10308N-formylanthranilic acid levelsGCST901999602.38e-04
10309NAA80 levelsGCST904699902.37e-04
103101-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levelsGCST902000832.37e-04
10311CCL13/CCL8 ratioGCST903136762.37e-04
10312IDP dMRI TBSS L1 Posterior corona radiata RGCST900041012.37e-04
10313Concentration of very small VLDL particlesGCST905008262.36e-04
10314ESAM/THPO ratioGCST903147192.36e-04
10315Immature fraction of reticulocytesGCST900023872.36e-04
10316Medication use (glucocorticoids)GCST900187802.35e-04
10317PRUNE2 levelsGCST904703492.35e-04
10318CASP10 levelsGCST904685422.35e-04
10319LILRB2 levelsGCST904697772.34e-04
10320Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T55ECGA0000552.34e-04
10321ALB levelsGCST904751062.34e-04
10322MMP9 levelsGCST904699232.33e-04
10323Osteoarthritis; localized | musculoskeletalUKBB000005952.33e-04
10324Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T101ECGA0001012.33e-04
10325HSPG2/VASN ratioGCST903150942.33e-04
10326EBAG9/TGFB1 ratioGCST903145702.33e-04
10327Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T53ECGA0000532.33e-04
10328Triglyceride levelsGCST902396632.32e-04
10329Total triglycerides levelsGCST905001262.32e-04
10330Hip indexGCST900200262.32e-04
10331CXCL13 levelsGCST904689262.32e-04
10332BA-exvivo lh area entorhinalGCST900032202.32e-04
10333ADAMTSL5 levelsGCST904682302.30e-04
10334Plasma methylsuccinate levels in chronic kidney diseaseGCST902655062.30e-04
10335CPB1/CTRB1 ratioGCST903142082.30e-04
10336T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119)GCST903209382.29e-04
10337Phosphate levels (UKB data field 30810)GCST904680942.29e-04
10338AMY1A or AMY1B or AMY1C levelsGCST904682972.28e-04
10339CD27/NECTIN4 ratioGCST903137752.28e-04
10340DAB2/NCK2 ratioGCST903143672.28e-04
10341Triglycerides to Total Lipids in Very Small VLDL percentageGCST905009002.28e-04
10342PTPRS levelsGCST904703872.27e-04
10343Heart rate variability (root mean square of successive differences)GCST902812632.27e-04
10344CCL4 levelsGCST904685832.27e-04
10345RGCC levelsGCST904704612.26e-04
10346RSPO1 levelsGCST904705032.26e-04
10347GFER/MAVS ratioGCST903149192.26e-04
10348Coronary revascularization (ANGIO or CABG)FING000003602.25e-04
10349Phospholipids in HDLGCST904974372.25e-04
10350LY6D levelsGCST904698212.25e-04
10351HEXIM1/TRIAP1 ratioGCST903150542.24e-04
10352Vitamin D levelsGCST0053672.24e-04
10353EHBP1 levelsGCST904690882.24e-04
10354SNAP29/SPARC ratioGCST903158602.23e-04
10355CHAC2 levelsGCST904687362.23e-04
10356OPTC levelsGCST904701282.23e-04
10357CD69/TXNDC5 ratioGCST903138892.23e-04
10358IGF1 levelsUKBB000003372.22e-04
10359Bone marrow fat fraction of thoracic vertebra 9GCST906523812.22e-04
10360ARL13B levelsGCST904683632.22e-04
10361TRAF2/WWP2 ratioGCST903159432.21e-04
10362SNAP29 levelsGCST904706922.21e-04
10363HSD11B1/SMPD1 ratioGCST903150822.19e-04
10364APP/VEGFC ratioGCST903133332.19e-04
10365NAGPA levelsGCST904699962.19e-04
10366ADGRF5 levelsGCST904682392.18e-04
10367FCRL2/LY9 ratioGCST903147992.18e-04
10368A4GALT levelsGCST904274572.18e-04
10369IGF1 levelsGCST901026232.18e-04
10370CD300C/LRRC25 ratioGCST903137902.17e-04
10371Osteoporosis NOS | musculoskeletalUKBB000005992.17e-04
10372GET3 levelsGCST904693242.16e-04
10373Urine glucuronide of C10H18O2 (12)* levels in chronic kidney diseaseGCST902651892.15e-04
10374CLEC3B levelsGCST904687702.15e-04
10375Cholesteryl Esters in Small HDLGCST904993862.15e-04
10376IL22 levelsGCST904695822.15e-04
10377CLEC10A levelsGCST904687632.14e-04
10378CXCL17/SFTPA2 ratioGCST903143412.13e-04
10379RGMA levelsGCST904704632.13e-04
10380VPS53 levelsGCST904710482.13e-04
10381NEXN levelsGCST904700302.12e-04
10382ENO2 levelsGCST904691102.12e-04
10383Cholesteryl esters in medium HDL (UKB data field 23569)GCST902696662.12e-04
10384GBA1 levelsGCST904232622.11e-04
10385Phospholipids to total lipids ratio in IDLGCST900928402.10e-04
10386KLKB1 levelsGCST904697082.09e-04
10387IL6ST/TYRO3 ratioGCST903151702.09e-04
10388Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020682.09e-04
10389aseg rh volume AmygdalaGCST900026422.09e-04
10390EGF/MGLL ratioGCST903146102.09e-04
10391BTN2A1/CSF1 ratioGCST903135412.08e-04
10392CLEC5A levelsGCST904687762.08e-04
10393Cholesteryl Esters in Medium LDLGCST904987392.08e-04
10394Concentration of medium HDL particlesGCST904986222.07e-04
10395IDP dMRI ProbtrackX ISOVF unc rGCST900045512.07e-04
10396GFRA1/SPON2 ratioGCST903149232.07e-04
10397EIF3J levelsGCST902411222.07e-04
10398FASLG levelsGCST904691912.06e-04
10399EIF4G1/NFATC1 ratioGCST903146372.06e-04
10400Other degenerative diseases of the nervous systemFING000009942.06e-04
10401MGLL/PTPN6 ratioGCST903154402.05e-04
10402Lymphocyte countGCST900023172.05e-04
10403SERPINB8 levelsGCST904705922.05e-04
10404Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2)GCST900440252.05e-04
10405CCL22/TIMP3 ratioGCST903136932.04e-04
10406CREG1/NAAA ratioGCST903142502.04e-04
10407T1 FreeSurfer aseg MaskVol-to-eTIVGCST903841922.04e-04
10408TPD52L2 levelsGCST904709422.04e-04
10409Calcific aortic valvular stenosis, operatedFING000002342.03e-04
10410COL2A1 levelsGCST904688162.03e-04
10411EPHB6/LAYN ratioGCST903146812.03e-04
10412Prescriptions - lipase inhibitor|obesityUKBB000006882.03e-04
10413Prescriptions - orlistat | lipase inhibitor,obesityUKBB000006952.03e-04
10414STC2 levelsGCST904707622.02e-04
10415Other disorders of eyelidFING000010262.02e-04
10416Cholesteryl Esters to Total Lipids in Medium HDL percentageGCST904985562.02e-04
10417aparc-DKTatlas lh volume pericalcarineGCST900028812.02e-04
10418LGALS1/LGALS8 ratioGCST903153142.01e-04
10419AMBP/ASGR1 ratioGCST903132512.01e-04
10420Triglycerides to Total Lipids in Large HDL percentageGCST904979062.01e-04
10421TGOLN2 levelsGCST904708502.01e-04
10422Triglycerides to Total Lipids in Large HDL percentageGCST904978962.01e-04
10423MESD/NCK2 ratioGCST903154212.00e-04
10424CKAP4 levelsGCST904687582.00e-04
10425Dihexosylceramide (d18:1/24:0) levelsGCST900253492.00e-04
10426BLOC1S3 levelsGCST904684501.99e-04
10427Cholesteryl Esters to Total Lipids in Medium LDL percentageGCST904987471.99e-04
10428Degree of unsaturationGCST905027491.99e-04
10429SLURP1 levelsGCST904706741.99e-04
10430HippSubfield lh volume Hippocampal-tailGCST900026681.99e-04
10431Monounsaturated fatty acid levelsGCST905023621.98e-04
10432Treatment/medication code - ventolin 100micrograms inhaler | MedicationsUKBB000008601.97e-04
10433AMBP/HAVCR1 ratioGCST903132541.96e-04
10434CACYBP levelsGCST904685241.96e-04
10435PRG3 levelsGCST904703231.96e-04
10436MATN3 levelsGCST904698651.96e-04
10437CST6 levelsGCST904688961.95e-04
10438Concentration of very large VLDL particlesGCST905006311.95e-04
10439Fluid intelligence score decline (difference score)GCST905658621.95e-04
10440Phosphatidylcholine (40:8) levelsGCST900255381.95e-04
10441FCRL2/KLB ratioGCST903147981.95e-04
10442Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005981.94e-04
10443HPGDS levelsGCST904694721.94e-04
10444Serum copper levelsGCST901005241.94e-04
10445Total Lipids in Medium LDLGCST904988061.93e-04
10446CD207 levelsGCST904686071.93e-04
10447TGFBR2 levelsGCST904708471.92e-04
10448Cholesteryl esters to total lipids in IDL percentage (UKB data field 23611)GCST902697081.92e-04
10449DNMBP/TBC1D5 ratioGCST903145191.92e-04
10450Volume of right basal nucleusGCST904750151.92e-04
10451FKBP5/MITD1 ratioGCST903148441.91e-04
10452Alkylphosphatidylcholine (O-34:1) levelsGCST900249251.91e-04
10453Nonalcoholic fatty liver diseaseGCST902750411.91e-04
10454Omega-6 fatty acids to total fatty acids percentageGCST905021271.91e-04
10455Red blood cell (erythrocyte) count | Blood countUKBB000007471.90e-04
10456red blood cell count (RBC, maximum, inv-norm transformed)GCST904763431.90e-04
10457Free Cholesterol in HDLGCST904973811.90e-04
10458HBEGF/PDGFA ratioGCST903150331.90e-04
10459Mean bone marrow fat fraction of thoracic vertebrae 8-12GCST906523851.90e-04
10460CD300E/CXCL10 ratioGCST903137961.90e-04
10461CDCP1 levelsGCST904686671.89e-04
10462FUT3 or FUT5 levelsGCST904692801.89e-04
10463Basophil countGCST900187261.89e-04
10464LBR levelsGCST904697441.89e-04
10465Bone marrow fat fraction of lumbar vertebra 2GCST906523871.89e-04
10466X-21364 levelsGCST902005661.89e-04
10467CSTB levelsGCST904688981.88e-04
10468Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T91ECGU0000911.88e-04
10469ARHGEF12 levelsGCST904683581.88e-04
10470CASP3/LYN ratioGCST903136351.88e-04
10471FOLR2/THY1 ratioGCST903148671.87e-04
10472Red blood cell (erythrocyte) distribution width | Blood countUKBB000007481.87e-04
10473Other disorders of breastFING000010181.87e-04
10474Total lipids in small HDL (UKB data field 23573)GCST902696701.87e-04
10475Phospholipids in small HDL (UKB data field 23574)GCST902696711.86e-04
10476GOPC/IRAK4 ratioGCST903149541.86e-04
10477SCARA5/TNC ratioGCST903158101.86e-04
10478WFDC1 levelsGCST904710741.85e-04
10479T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 111)GCST903209301.85e-04
10480Left-hemisphere limbic network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027321.85e-04
10481Sum eosinophil basophil countsGCST0046241.85e-04
10482RAB6A levelsGCST904704121.84e-04
10483MARCO/SIGLEC1 ratioGCST903153871.84e-04
10484VAV3 levelsGCST904710301.84e-04
10485Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T106ECGU0001061.84e-04
10486Bioavailable testosterone levelsGCST900121021.83e-04
10487CLEC1B/HEXIM1 ratioGCST903140931.82e-04
10488Platelet count during second trimester of pregnancyGCST903022251.82e-04
10489Triacylglycerol_53:3_[M+NH4]1+ levelsGCST900605281.82e-04
10490ADAMTS8 levelsGCST904682271.82e-04
10491REST UKBBICA NODEamps25 0001GCST903854841.82e-04
10492Asthma (adult onset)GCST0077991.81e-04
10493FCER2/TNFRSF9 ratioGCST903147911.81e-04
10494NINJ1 levelsGCST904700491.81e-04
10495Brain glioblastoma, excluding all cancers (controls excluding all cancers)FING000002251.80e-04
10496ANGPT2 levelsGCST904683011.80e-04
10497CA2/NSFL1C ratioGCST903135801.79e-04
10498Platelet distribution width (UKB data field 30110)GCST904680971.77e-04
10499KLK1 levelsGCST904697021.77e-04
10500CRISP3 levelsGCST904688661.76e-04
10501RAB2B levelsGCST904704061.75e-04
10502ESAM/TNFRSF14 ratioGCST903147201.75e-04
10503Concentration of large HDL particlesGCST904978361.75e-04
10504Triglycerides to Total Lipids in Medium HDL percentageGCST904986891.75e-04
10505Cholesteryl Esters in Small VLDLGCST904997821.75e-04
10506Inflammatory bowel diseaseGCST904321821.74e-04
10507ANPEP levelsGCST904683131.74e-04
10508Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T44ECGA0000441.74e-04
10509AFM levelsGCST904682491.74e-04
10510Systolic blood pressureGCST904727811.74e-04
10511MSLN levelsGCST904699481.73e-04
10512PCDH17/TEK ratioGCST903156061.73e-04
10513aparc-pial lh area superiorparietalGCST900031691.73e-04
10514GAS6 levelsGCST904693051.72e-04
10515SKAP1 levelsGCST904706451.72e-04
10516DYNLL1 levelsGCST902409841.71e-04
10517PPIB levelsGCST904702911.71e-04
10518T1 FreeSurfer aseg Left-PallidumGCST903841461.70e-04
10519VEGFA levelsGCST900119951.70e-04
10520CLEC4M levelsGCST904687751.70e-04
10521LTBR levelsGCST902431761.70e-04
10522METAP2 levelsGCST904698941.70e-04
10523Cholesterol esters in very large HDLGCST905003441.70e-04
10524CDHR2 levelsGCST904686791.70e-04
10525NEO1 levelsGCST904700291.69e-04
10526Hippocampal subfield right CA1 volume (head)GCST902679611.69e-04
10527C7 levelsGCST904685021.69e-04
10528SCARF2/TNFRSF21 ratioGCST903158131.69e-04
10529Alkenylphosphatidylethanolamine (P-20:0/18:2) levelsGCST900256831.68e-04
10530Chronic pancreatitisGCST900186011.67e-04
10531Other non-toxic goitre | Disorders of thyroid glandUKBB000006171.66e-04
10532VWF levelsGCST904710651.65e-04
10533Left hippocampal volume (tail)GCST902679511.65e-04
10534KIFBP levelsGCST904696831.65e-04
10535SYAP1 levelsGCST904707921.65e-04
10536EPS8L2 levelsGCST904691381.64e-04
10537ATG16L1 levelsGCST904683831.64e-04
10538Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T117ECGA0001171.64e-04
10539Total fatty acid levelsGCST905027221.64e-04
10540DNAJB1 levelsGCST904690121.64e-04
10541Concentration of medium LDL particlesGCST904988191.63e-04
10542Erythematous conditions (PheCode 695)GCST904761771.62e-04
10543ErysipelasFING000005181.62e-04
10544AMBP levelsGCST904682881.62e-04
10545MYDGF levelsGCST904699721.62e-04
10546OTUD7B levelsGCST904701371.62e-04
10547FCRL6/KLRD1 ratioGCST903148071.62e-04
10548NXPH3 levelsGCST904701121.61e-04
10549ZFYVE19 levelsGCST904710981.61e-04
10550TMPRSS11D levelsGCST904708911.61e-04
10551CD83 levelsGCST904686521.61e-04
10552CD274 levelsGCST904686131.60e-04
10553Adhesive capsulitis of shoulderFING000000431.59e-04
10554Triglycerides in HDLGCST904974671.59e-04
10555FAM3D levelsGCST904691881.59e-04
10556TNFRSF10B levelsGCST900120211.58e-04
10557PsoriasisGCST904681471.58e-04
10558Docosahexaenoic acid levelsGCST905022581.58e-04
10559ITGB1BP2/LAT2 ratioGCST903152121.57e-04
10560NPPC levelsGCST904700751.57e-04
10561LRPAP1 levelsGCST904698001.57e-04
10562TIA1/USP8 ratioGCST903159201.57e-04
10563C1R levelsGCST904684931.56e-04
10564RELT/TNFRSF1A ratioGCST903157671.56e-04
10565Clonal haematopoiesis of indeterminate potential (DNMT3A mutation)GCST901652711.56e-04
10566CERT levelsGCST904687171.56e-04
10567GFRAL levelsGCST904693311.55e-04
10568RNF41/WWP2 ratioGCST903157821.55e-04
10569AMOTL2 levelsGCST904682941.55e-04
10570TGFA levelsGCST904708421.55e-04
10571PGD levelsGCST904702171.55e-04
10572CIAPIN1/SNAP29 ratioGCST903140671.54e-04
10573Total lipids in very large VLDLGCST905006141.54e-04
10574CD55 levelsGCST904686371.53e-04
10575OMD levelsGCST904701231.53e-04
10576IGF2R/RNASET2 ratioGCST903151321.52e-04
10577MED18/SMAD1 ratioGCST903154131.52e-04
10578T1 CAT volume L LeftAccumbensGCST903841081.52e-04
10579Triglycerides x anxiety interaction (2df test)GCST905706771.51e-04
10580DLK1/RGMB ratioGCST903144931.51e-04
10581AFP levelsGCST904682501.50e-04
10582Platelet countGCST900024021.50e-04
10583Omega-3 fatty acid levelsGCST905020641.50e-04
10584Phospholipids to Total Lipids in Very Large VLDL percentageGCST905006651.49e-04
10585CD59/SCARB2 ratioGCST903138591.49e-04
10586Provencibacterium abundance in stoolGCST900325281.49e-04
10587Blood cell traits latent factor 5 (platelet)GCST905592471.49e-04
10588Pure hypercholesterolaemiaFING000012301.49e-04
10589CCL18/TFPI ratioGCST903136911.49e-04
10590DTI TBSS L1 External capsule RGCST903844601.48e-04
10591CCN2 levelsGCST904685881.48e-04
10592BCHE levelsGCST904684291.48e-04
10593ITGB2 levelsGCST904696441.47e-04
10594Other and unspecified nerve root and plexus disorders, also in other diseasesFING000009441.47e-04
10595GRAP2/TYMP ratioGCST903149901.46e-04
10596DIABLO/MITD1 ratioGCST903144671.46e-04
10597CD101 levelsGCST904685961.46e-04
10598DorsopathiesFING000004731.46e-04
10599OSCAR levelsGCST904701311.46e-04
10600SERPINB6/TXNDC5 ratioGCST903158321.45e-04
10601UFD1 levelsGCST904710051.45e-04
10602Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007161.45e-04
10603Progressive vascular leukoencephalopathyFING000012181.45e-04
10604X-18922 levelsGCST902005781.45e-04
10605DNAJA2/FIS1 ratioGCST903145011.44e-04
10606Clonal hematopoiesis (large clone)GCST901026211.44e-04
10607Blood cell traits latent factor 21 (red cell)GCST905592631.44e-04
10608RARRES2/ST6GAL1 ratioGCST903157591.43e-04
10609F9/FETUB ratioGCST903147461.43e-04
10610FOLR2 levelsGCST904692601.43e-04
10611Polyunsaturated fatty acids to total fatty acids percentageGCST905021791.42e-04
10612CC2D1A/STAMBP ratioGCST903136641.42e-04
10613ANGPT1/MPIG6B ratioGCST903132651.41e-04
10614DNA methylation PhenoAge accelerationGCST900142921.41e-04
10615BCR/CLIP2 ratioGCST903134861.40e-04
10616PLA2G1B/PRSS2 ratioGCST903156651.40e-04
10617Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB000000151.40e-04
10618Polyunsaturated fatty acid levelsGCST905026221.40e-04
10619EFHD1 levelsGCST904690791.40e-04
10620Blood cell traits latent factor 10 (platelet)GCST905592521.40e-04
10621Phospholipid levels in small HDLGCST900929521.40e-04
10622FKBP14 levelsGCST904692411.39e-04
10623Autorefraction - 6mm strong meridian angle (right) | EyesightUKBB000000781.39e-04
10624Atherosclerosis, excluding cerebral and coronary sclerosisFING000001231.39e-04
10625BA-exvivo lh volume V1GCST900028441.39e-04
10626Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)GCST902696841.38e-04
10627Total cholesterol levelsGCST905000151.38e-04
10628Cholesterol levels in very large HDLGCST905003221.38e-04
10629Illnesses of mother - High blood pressure | Family historyUKBB000003481.38e-04
10630EREG/MPIG6B ratioGCST903147041.37e-04
10631Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T187ECGU0001871.37e-04
10632CD1C levelsGCST904686041.37e-04
10633LGALS7 or LGALS7B levelsGCST904697631.37e-04
10634STK11 levelsGCST904707651.37e-04
10635SPP1 levelsGCST904707331.36e-04
10636AHSG levelsGCST904682631.36e-04
10637ACVRL1/TNFRSF10B ratioGCST903131581.36e-04
10638C1QTNF9 levelsGCST904684911.36e-04
10639CFHR5 levelsGCST904687281.36e-04
10640ANGPTL7 levelsGCST904683061.35e-04
10641X-21467 levelsGCST902005941.35e-04
10642Total lipid levels in small HDLGCST900929501.35e-04
10643CCDC80 levelsGCST904685621.35e-04
10644NUCB2/TRIAP1 ratioGCST903155771.35e-04
10645ACE2/GGT1 ratioGCST903131531.34e-04
10646High light scatter reticulocyte percentage of red cellsGCST0046121.34e-04
10647AIF1 levelsGCST904682671.34e-04
10648FGFBP1 levelsGCST904692301.34e-04
10649Lymphocyte countGCST900023161.34e-04
10650TNFRSF10B levelsGCST904709001.33e-04
10651HSPG2/SMOC2 ratioGCST903150931.33e-04
10652TNFRSF1B levelsGCST904709111.33e-04
10653SPINK5 levelsGCST904707241.33e-04
10654YARS1 levelsGCST904710871.33e-04
10655Carotid artery plaque burdenGCST905030761.33e-04
10656F3 levelsGCST900120141.32e-04
10657INHBC levelsGCST904696151.32e-04
10658GZMA/LTA ratioGCST903150121.32e-04
10659red blood cell count (RBC, minimum, inv-norm transformed)GCST904763531.32e-04
10660LAMA4/NID1 ratioGCST903152721.31e-04
10661EDAR/ENO2 ratioGCST903145741.31e-04
10662Intrinsic epigenetic age accelerationGCST900142901.31e-04
10663FGD3 levelsGCST904692171.30e-04
10664Other cataract | Disorders of lensUKBB000006021.29e-04
10665Mean platelet volumeGCST900023951.29e-04
10666TNFRSF1A levelsGCST904709101.29e-04
10667Polycystic ovarian syndrome, consortium definitionFING000011841.29e-04
10668CD22/FOLR2 ratioGCST903137581.28e-04
10669Bone marrow fat fraction of lumbar vertebra 3GCST906523881.28e-04
10670Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9)GCST904759081.28e-04
10671PRRT3 levelsGCST904703401.28e-04
10672CA4 levelsGCST904685131.28e-04
10673Glomerular filtration rate (cystatin C)GCST0033751.27e-04
10674Total lipids in small HDLGCST904994431.27e-04
10675TIA1 levelsGCST904708621.27e-04
10676Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T98ECGU0000981.27e-04
10677PCSK7 levelsGCST904701761.27e-04
10678NBL1 levelsGCST904700011.27e-04
10679ST8SIA1 levelsGCST904707541.27e-04
10680PACS2 levelsGCST904701411.27e-04
10681ACVRL1/TNFRSF19 ratioGCST903131591.27e-04
10682CHRDL2 levelsGCST904687511.26e-04
10683IL1RN levelsGCST904695761.26e-04
10684ARHGAP1 levelsGCST904683521.26e-04
10685Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levelsGCST900603111.26e-04
10686HippSubfield rh volume CA4-headGCST900027041.26e-04
10687SH2B3 levelsGCST904706161.26e-04
10688Phospholipids to total lipids in small HDL percentage (UKB data field 23644)GCST902697411.25e-04
10689Lysophosphatidylcholine (22:6) [sn2] levelsGCST900241851.25e-04
10690CHRDL1 levelsGCST904687501.25e-04
10691SPINK2 levelsGCST904707221.25e-04
10692SMAD1 levelsGCST904706751.25e-04
10693Triglycerides to Total Lipids in Very Large VLDL percentageGCST905006951.25e-04
10694CSF1/IL10RB ratioGCST903142841.24e-04
10695Triacylglycerol_54:5_[M+NH4]1+ levelsGCST900605391.24e-04
10696HAVCR2/TNFRSF1B ratioGCST903150301.23e-04
10697PCDH17 levelsGCST904701691.23e-04
10698SEPTIN3 levelsGCST904705761.23e-04
10699IDP dMRI ProbtrackX OD fmiGCST900044611.23e-04
10700WASF1 levelsGCST904710671.23e-04
10701CASP8/PPP3R1 ratioGCST903136541.23e-04
10702Calcific aortic valve stenosisGCST903102931.23e-04
10703Waist-hip indexGCST900200271.23e-04
10704Monocyte countGCST900023931.23e-04
10705CLEC4D/MANSC1 ratioGCST903141121.23e-04
10706Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020691.22e-04
10707CCN5 levelsGCST904685911.22e-04
10708Lymphocyte countGCST900259841.22e-04
10709Myocardial infarction (PheCode 411.2)GCST904759321.22e-04
10710Platelet distribution widthGCST900024011.22e-04
10711ACE2 levelsGCST904681971.22e-04
10712IL3RA levelsGCST904695961.21e-04
10713CLEC1B/GP1BA ratioGCST903140911.21e-04
10714T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108)GCST903206711.21e-04
10715DTI autoptx MD str r tractGCST903852441.21e-04
10716Phospholipid levels in chylomicrons and extremely large VLDLGCST905010311.21e-04
10717monocyte (absolute count, maximum, inv-norm transformed)GCST904754991.21e-04
10718Mean bone marrow fat fraction of lumbar vertebrae 1-5GCST906523911.20e-04
10719CD5 levelsGCST904686411.20e-04
10720LY6D/WFDC12 ratioGCST903153461.20e-04
10721X-12707 levelsGCST902005021.20e-04
10722Asthma/COPD (KELA code 203)FING000001211.20e-04
10723TST levelsGCST904709821.19e-04
10724NCK2/PLA2G4A ratioGCST903155241.19e-04
10725BA-exvivo lh area BA6GCST900032131.19e-04
10726Monocyte percentage | Blood countUKBB000004801.19e-04
10727ADGRE2/CD58 ratioGCST903131751.19e-04
10728HMCN2 levelsGCST904694611.19e-04
10729Sphingomyelin_36:1_[M+H]1+ levelsGCST900602661.19e-04
10730TRIM25 levelsGCST904709661.18e-04
10731Waist-to-hip ratio adjusted for BMIGCST900200251.18e-04
10732Reticulocyte fraction of red cellsGCST900024061.18e-04
10733Fracture of forearmFING000005541.18e-04
10734LCP1 levelsGCST904697481.18e-04
10735Inguinal herniaGCST900186481.17e-04
10736Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T122ECGU0001221.17e-04
10737A body shape indexGCST0122311.17e-04
10738Cholesteryl Esters in VLDLGCST905002111.17e-04
10739SMAD2 levelsGCST904706761.17e-04
10740THBD levelsGCST904708531.17e-04
10741NME3 levelsGCST904700551.16e-04
10742Triglycerides in VLDLGCST905003041.16e-04
10743CXADR/GGT1 ratioGCST903143281.16e-04
10744Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020751.16e-04
10745Red blood cell countGCST900023641.15e-04
10746Heart rate variability (standard deviation of normal-to-normal intervals)GCST902812651.15e-04
10747Platelet count | Blood countUKBB000006461.15e-04
10748Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T57ECGA0000571.15e-04
10749Left-hemisphere control network to caudate white-matter structural connectivityGCST903027531.15e-04
10750Syncope and collapse | symptomsUKBB000008011.15e-04
10751PVALB levelsGCST904703931.14e-04
10752Takes medication for prostate cancer?GCST904751871.14e-04
10753FOLR2/MSR1 ratioGCST903148661.14e-04
10754Heart valve replaced (PheCode 395.6)GCST904759151.14e-04
10755PIK3IP1 levelsGCST904702341.14e-04
10756ANGPT1/PDGFA ratioGCST903132661.14e-04
10757CCL22/PDGFB ratioGCST903136921.14e-04
10758Otitis externaFING000011281.13e-04
10759CA4/FOLR2 ratioGCST903135851.13e-04
10760DDAH1 levelsGCST904689661.13e-04
10761ICD10 N84: Polyp of female genital tractGCST904542161.13e-04
10762Left-hemisphere control network to pallidum white-matter structural connectivityGCST903027551.13e-04
10763ITGB1/MCAM ratioGCST903152261.13e-04
10764Diarrhoea and gastroenteritis of presumed infectious originFING000004201.13e-04
10765ARHGEF5 levelsGCST904683601.13e-04
10766LY96 levelsGCST904698231.12e-04
10767DOK2 levelsGCST904690291.12e-04
10768PPP1R2 levelsGCST904703041.12e-04
10769GP6 levelsGCST904693841.11e-04
10770ALPP/LAMP3 ratioGCST903132491.11e-04
10771Height decline (difference score)GCST905658631.10e-04
10772Monocyte count | Blood countUKBB000004791.10e-04
10773ESAM/SORT1 ratioGCST903147161.10e-04
10774MITD1 levelsGCST904699101.10e-04
10775NUDT16 levelsGCST904701051.10e-04
10776COLEC12/NBL1 ratioGCST903141831.09e-04
10777platelet count (mean, inv-norm transformed)GCST904762991.09e-04
10778COLEC12 levelsGCST904688241.09e-04
10779WARS levelsGCST904710661.09e-04
10780FOXO1/USP8 ratioGCST903148791.09e-04
10781PRTG levelsGCST904703471.09e-04
10782Triacylglycerol_54:7_[M+NH4]1+ levelsGCST900605361.09e-04
10783TNFRSF21 levelsGCST904709121.08e-04
10784Triacylglycerol (48:2) [NL-16:0] levelsGCST900251431.08e-04
10785APP/BIN2 ratioGCST903133161.08e-04
10786DIABLO/PRKAR1A ratioGCST903144691.08e-04
10787Bone marrow fat fraction of thoracic vertebra 10GCST906523821.07e-04
10788PLA2G7 levelsGCST904702491.07e-04
10789ATP5IF1 levelsGCST904683921.07e-04
10790DAG1/PDGFA ratioGCST903143781.07e-04
10791BACH1/SNAP23 ratioGCST903134461.06e-04
10792MCFD2/VSIR ratioGCST903154111.06e-04
10793Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T139ECGU0001391.06e-04
10794VASH1 levelsGCST904710261.06e-04
10795HSPB1/PLIN3 ratioGCST903150881.06e-04
10796CD69/TIA1 ratioGCST903138881.06e-04
10797Bone marrow fat fraction of lumbar vertebra 5GCST906523901.06e-04
10798FLI1 levelsGCST904692471.05e-04
10799Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T54ECGA0000541.05e-04
10800KLK6 levelsGCST904697051.05e-04
10801IL18 levelsGCST904695671.05e-04
10802CXCL12 levelsGCST904689251.05e-04
10803LYN/SIRT2 ratioGCST903153491.05e-04
10804Monocyte count (UKB data field 30130)GCST904680901.05e-04
10805Enthesopathy (PheCode 726.1)GCST904762391.05e-04
10806Mean platelet volume during third trimester of pregnancyGCST903022311.05e-04
10807CD5/IL16 ratioGCST903138611.04e-04
10808CDSN/NECTIN4 ratioGCST903139981.04e-04
10809APOB/APOA1 ratioGCST904971561.03e-04
10810NECTIN2/SDC1 ratioGCST903155291.03e-04
10811HEG1 levelsGCST904694441.03e-04
10812FCAMR levelsGCST904691961.03e-04
10813Abdominal aortic aneurysm (AAA)FING000000011.03e-04
10814BIN2/PDLIM7 ratioGCST903135091.02e-04
10815ANGPT1/CCN2 ratioGCST903132611.02e-04
10816IL7R levelsGCST904696051.02e-04
10817GBP1 levelsGCST904693111.01e-04
10818DRAXIN levelsGCST904690381.01e-04
10819CD6/EZR ratioGCST903138901.01e-04
10820Right ventricular ejection fraction (MTAG)GCST901345951.01e-04
10821Urea levels (UKB data field 30670)GCST904681081.00e-04
10822CD302/IL12A_IL12B ratioGCST903138061.00e-04
10823KLK8 levelsGCST904697071.00e-04
10824C19ORF12 levelsGCST904684839.96e-05
10825Pulse pressure (BMI adjusted)GCST903351679.95e-05
10826PZP levelsGCST904703999.94e-05
10827GOLM2/ITGA5 ratioGCST903149519.93e-05
10828FBP1 levelsGCST904691959.93e-05
10829HippSubfield rh volume presubiculum-headGCST900026959.91e-05
10830PDGFB/USP8 ratioGCST903156339.79e-05
10831HSIL lesion of the cervix uteriFING000006249.79e-05
10832DTI autoptx FA ilf r tractGCST903851279.76e-05
10833IDP dMRI TBSS L3 Uncinate fasciculus RGCST900042159.75e-05
10834COLEC12/TGFBR2 ratioGCST903141869.75e-05
10835Cholesteryl esters to total lipids in very large VLDL percentage (UKB data field 23586)GCST902696839.75e-05
10836CDKN2D levelsGCST904686859.74e-05
10837aparc-Desikan lh volume pericalcarineGCST900027889.71e-05
10838Lymphocyte count (UKB data field 30120)GCST904680829.70e-05
10839MIA levelsGCST904699039.70e-05
10840CRYZL1 levelsGCST904688789.70e-05
10841CANT1/GSTA1 ratioGCST903136169.69e-05
10842EREG/F2R ratioGCST903147009.67e-05
10843SNX18 levelsGCST904707009.64e-05
10844TNIP1 levelsGCST904709259.63e-05
10845IL31RA levelsGCST904695899.63e-05
10846Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021689.60e-05
10847FRZB levelsGCST904692699.59e-05
10848Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T58ECGA0000589.57e-05
10849Omega-3 fatty acid levelsGCST905020629.55e-05
10850MAP2K6/TBL1X ratioGCST903153789.49e-05
10851Blood cell traits latent factor 6 (red cell (and basophil))GCST905592489.49e-05
10852AKT1S1 levelsGCST904682769.48e-05
10853CASP2 levelsGCST904685449.47e-05
10854MAVS/MYO9B ratioGCST903153909.46e-05
10855Osteoporosis, osteopenia and pathological fracture | musculoskeletalUKBB000006009.45e-05
10856FKBP4/WWP2 ratioGCST903148429.44e-05
10857CA5A/GRPEL1 ratioGCST903135909.43e-05
10858SPARCL1 levelsGCST904707179.43e-05
10859DAB2/TBL1X ratioGCST903143689.42e-05
10860Blood cell traits latent factor 7 (white cell)GCST905592499.41e-05
10861SDC4/SERPINE1 ratioGCST903158199.39e-05
10862APP/TMSB10 ratioGCST903133329.39e-05
10863IGSF8/VSIR ratioGCST903151419.37e-05
10864MEP1A levelsGCST904698879.36e-05
10865SERPINE1/USP8 ratioGCST903158359.36e-05
10866PRG2 levelsGCST904703229.35e-05
10867Mean diameter of VLDL particlesGCST901327349.32e-05
10868BACH1 levelsGCST904684159.29e-05
10869MAPKAPK2 levelsGCST904698589.27e-05
10870CDA levelsGCST904686609.24e-05
10871Cholesteryl Esters in HDLGCST904973689.18e-05
10872CD79B/FCRL1 ratioGCST903138999.16e-05
10873MAVS/SCAMP3 ratioGCST903153969.15e-05
10874EDAR/F11R ratioGCST903145769.14e-05
10875Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453)GCST902695509.09e-05
10876HSPG2 levelsGCST904694919.08e-05
10877DTI TBSS MD Anterior corona radiata RGCST903845949.08e-05
10878PlateletcritGCST0046079.06e-05
10879Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025939.03e-05
10880Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024109.01e-05
10881LAMP3 levelsGCST904697358.99e-05
10882TBCC levelsGCST904708148.96e-05
10883IL15/KLRD1 ratioGCST903151498.96e-05
10884FracturesGCST0069808.96e-05
10885EFCAB14 levelsGCST904690768.93e-05
10886LMOD1 levelsGCST904697838.93e-05
10887KLRD1 levelsGCST904697118.93e-05
10888Succinylcarnitine levelsGCST902438748.91e-05
10889RABEP1 levelsGCST904704148.91e-05
10890GZMA/TNFRSF4 ratioGCST903150138.86e-05
10891Phospholipids in large VLDLGCST904982478.86e-05
10892GFRA2/IL12A_IL12B ratioGCST903149258.86e-05
10893CKB levelsGCST904687598.85e-05
10894EBI3_IL27/VCAM1 ratioGCST903145728.84e-05
10895Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T105ECGA0001058.82e-05
10896Lymphocyte count | Blood countUKBB000004118.80e-05
10897PDGFA/SCARF1 ratioGCST903156178.79e-05
10898PCDH17/PTPRM ratioGCST903156038.77e-05
10899LRRC59 levelsGCST904698048.77e-05
10900WIF1 levelsGCST904710788.76e-05
10901Myocardial fractal dimension (slice 5)GCST900002918.76e-05
10902Peripheral vascular disease, unspecified (PheCode 443.9)GCST904759988.75e-05
10903ArthropathiesFING000001078.73e-05
10904Ulcerative colitisGCST900187138.72e-05
10905HippSubfield lh volume Whole-hippocampusGCST900026898.70e-05
10906Monocyte countGCST900259508.67e-05
10907CD80 levelsGCST904686508.66e-05
10908Heart rate variability (corrected standard deviation of normal-to-normal intervals)GCST902812668.64e-05
10909EDA2R levelsGCST904690678.61e-05
10910NCAN levelsGCST906185598.61e-05
10911CST7 levelsGCST904688978.59e-05
10912FHIT/GLOD4 ratioGCST903148178.58e-05
10913Omega-6 fatty acids to total fatty acids percentageGCST905025298.58e-05
10914IL1RN levelsGCST900120048.58e-05
10915Shoulder lesions | Other soft tissue disordersUKBB000007698.57e-05
10916Cholesteryl Esters to Total Lipids in Very Small VLDL percentageGCST905007548.57e-05
10917Triglycerides to Total Lipids in Medium HDL percentageGCST904986828.54e-05
10918PDCD1 levelsGCST904701818.51e-05
10919Omega-3 fatty acids to total fatty acids percentageGCST905024498.49e-05
10920SERPING1 levelsGCST904706008.48e-05
10921CCL18/RARRES2 ratioGCST903136908.48e-05
10922Cholesterol in Medium LDLGCST904987078.47e-05
10923Triglycerides to total lipids ratio in large VLDLGCST900928798.46e-05
10924EDAR/ITGB1BP2 ratioGCST903145808.41e-05
10925F3 levelsGCST904691708.38e-05
10926GP6/TMSB10 ratioGCST903149758.36e-05
10927T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 43)GCST903206068.36e-05
10928DTI autoptx MD ifo l tractGCST903852328.35e-05
10929IL10RB levelsGCST904695458.33e-05
10930DTI TBSS L2 FornixGCST903844818.33e-05
10931ADA2/VCAM1 ratioGCST903131678.31e-05
10932APRT/NSFL1C ratioGCST903133378.29e-05
10933monocyte (fraction, mean, inv-norm transformed)GCST904755118.28e-05
10934LCN2/S100A12 ratioGCST903153098.27e-05
10935Saturated fatty acids to total fatty acids percentageGCST905022058.25e-05
10936aparc-Desikan lh area superiorparietalGCST900031018.25e-05
10937FUT8 levelsGCST904692818.24e-05
10938TMSB10 levelsGCST904708948.24e-05
10939Percentage of M9 (GP18)GCST906686968.24e-05
10940EDAR/EGF ratioGCST903145738.23e-05
10941IL1RL1 levelsGCST904695748.19e-05
10942Total Alkenylphosphatidylcholine levelsGCST900258358.19e-05
10943CD300C/NBL1 ratioGCST903137928.18e-05
10944LRRC25 levelsGCST904698018.17e-05
10945KIAA2013 levelsGCST904696798.16e-05
10946ITGAM/ITGAV ratioGCST903152098.15e-05
10947Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023988.13e-05
10948CD27 levelsGCST904686158.08e-05
10949SNAP23/TBL1X ratioGCST903158568.07e-05
10950DNA methylation Hannum age accelerationGCST900142898.07e-05
10951Alkylphosphatidylcholine (O-34:1) levelsGCST900255518.04e-05
10952CALCOCO1/METAP2 ratioGCST903136068.02e-05
10953CD36 levelsGCST904686278.01e-05
10954SpondylosisFING000013277.99e-05
10955Triglycerides in large LDLGCST904980837.99e-05
10956CLEC4G levelsGCST904687747.99e-05
10957NFATC3 levelsGCST904700347.99e-05
10958EPHA1 levelsGCST904691297.99e-05
10959T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54)GCST903208737.95e-05
10960ITGB1BP2 levelsGCST904696427.93e-05
10961GSTA1/PBLD ratioGCST903149947.93e-05
10962FOXJ3 levelsGCST904692647.92e-05
10963Mean platelet (thrombocyte) volume | Blood countUKBB000004507.91e-05
10964Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020777.89e-05
10965FAM3C levelsGCST904691877.88e-05
10966platelet count (maximum, inv-norm transformed)GCST904762967.83e-05
10967GoutFING000005877.82e-05
10968DLL1 levelsGCST904690047.82e-05
10969Ulcerative colitisGCST904467957.80e-05
10970PTPN6/YES1 ratioGCST903157507.78e-05
10971NIT1 levelsGCST904700507.78e-05
10972MINK1 levelsGCST904699097.76e-05
10973Tonsillectomy and adenotomyFING000013677.76e-05
10974KLK8 levelsGCST902416807.76e-05
10975IL6ST/MARCO ratioGCST903151677.75e-05
10976PTPRK levelsGCST904703837.75e-05
10977monocyte (absolute count, mean, inv-norm transformed)GCST904755027.74e-05
10978Left ventricular outflow tract obstruction (LVOTO), broad definitionFING000007177.73e-05
10979Platelet countGCST0046037.72e-05
10980MEGF9/MET ratioGCST903154187.71e-05
10981KLRD1/LY9 ratioGCST903152617.70e-05
10982TRIM21 levelsGCST904709647.69e-05
10983STX16 levelsGCST904707697.67e-05
10984ALB/Globulin ratioUKBB000000207.67e-05
10985P4HB levelsGCST904701407.64e-05
10986PTPN1/TDRKH ratioGCST903157457.63e-05
10987IDP dMRI TBSS L2 Sagittal stratum LGCST900041547.63e-05
10988Insomnia complaintsGCST0064887.62e-05
10989ALB levelsGCST900928077.60e-05
10990Triglycerides to Total Lipids in Small HDL percentageGCST904995307.57e-05
10991CFI levelsGCST902407827.57e-05
10992SDCCAG8 levelsGCST904705607.55e-05
10993Facial ageing | Sun exposureUKBB000002337.51e-05
10994CCL21 levelsGCST904685737.45e-05
10995ESAM/PDGFB ratioGCST903147147.45e-05
10996neutrophil (absolute count, minimum, inv-norm transformed)GCST904755327.43e-05
10997aseg rh number HolesBeforeFixingGCST900026477.43e-05
10998CSPG4 levelsGCST904688907.41e-05
10999REG1B/REG3A ratioGCST903157657.40e-05
11000Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T493ECGU0004937.40e-05